The score is driven primarily by severe financial strain (large ongoing losses, negative equity, and continued cash burn). Technicals add downside risk with price below all key moving averages and negative MACD, partially tempered by near-oversold RSI. Valuation provides little support because the company is unprofitable (negative P/E) and no dividend yield is available.
Positive Factors
Proprietary aluminum-foam product niche
Cymat's core technology—proprietary aluminum foam—targets structural, impact-mitigation and vibration-damping use cases. That product specialization creates durable competitive differentiation in transport and industrial markets where lightweight, energy-absorbing materials are structurally valued and can support multi-year supply relationships.
Demonstrated prior gross-margin profitability
The company achieved positive gross margin in the recent prior annual period, indicating the manufacturing economics can be profitable at sufficient scale or mix. This suggests margins are recoverable if volumes, pricing, or production efficiency improve, making cost structure not inherently unprofitable long term.
Signs of modest cash-flow improvement trend
Trailing metrics show reduced negative FCF/OCF versus prior troughs, indicating early operational stabilization. While cash generation remains negative, an improving trajectory is a durable operational signal: it implies management actions or demand improvements may be beginning to reduce cash burn over the coming quarters if sustained.
Negative Factors
Negative shareholders' equity and high leverage
The balance sheet is structurally stressed: negative equity and meaningful debt versus a small asset base materially increase insolvency and refinancing risk. This reduces financial flexibility and makes the company sensitive to interest, covenant, or capital access shocks over the medium term without recapitalization or sustained profit recovery.
Deep and persistent operating losses
Very large net losses and negative operating margins indicate the core business currently fails to cover fixed and variable costs. Persistent negative profitability forces ongoing capital raises or debt use, undermining long-term sustainability unless the company delivers durable revenue and margin improvement.
Declining revenue and weakening sales trend
Top-line contraction and steep reported revenue growth deterioration signal demand or commercial execution problems. Falling revenue reduces ability to leverage prior profitable cost structure, making margin recovery and cash-flow stabilization harder and increasing the likelihood management must cut costs or seek external capital.
Cymat Technologies (CYM) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$8.03M
Dividend YieldN/A
Average Volume (3M)118.58K
Price to Earnings (P/E)―
Beta (1Y)1.11
Revenue Growth-25.74%
EPS Growth2.28%
CountryCA
Employees11
SectorGeneral
Sector StrengthN/A
IndustryManufacturing - Metal Fabrication
Share Statistics
EPS (TTM)-0.01
Shares Outstanding100,337,330
10 Day Avg. Volume20,030
30 Day Avg. Volume118,582
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)-2.03
Price to Sales (P/S)2.58
P/FCF Ratio-5.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cymat Technologies Business Overview & Revenue Model
Company DescriptionCymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company provides architectural materials under the Alusion brand name; and automotive and blast mitigation products under the SmartMetal brand name. It serves defense and military, automotive and transportation, architectural, and other application. The company was incorporated in 2006 and is based in Mississauga, Canada.
How the Company Makes MoneyCymat makes money primarily by selling its proprietary aluminum foam materials and related product forms to customers that incorporate the material into end-use applications (e.g., crash/impact energy management and other industrial uses). Revenue is generated through commercial supply arrangements for these foam-metal products, where Cymat is compensated per unit/material supplied under customer purchase orders and/or longer-term supply agreements. null
Cymat Technologies Financial Statement Overview
Summary
Very weak fundamentals: TTM revenue declined (-4.2%), gross profit turned negative (gross margin ~-2.4%), and losses are extremely large versus sales (net margin ~-222%) with negative EBIT/EBITDA. The balance sheet is highly stressed with negative equity (~-$3.8M) and meaningful debt (~$5.8M) against a small asset base (~$3.7M). Cash flow remains deeply negative (TTM OCF and FCF about -$2.75M and -$2.77M), indicating ongoing cash burn despite a modest improvement trend from a negative base.
Income Statement
12
Very Negative
TTM (Trailing-Twelve-Months) results show deep and worsening profitability pressure: revenue declined (-4.2% growth) and gross profit turned slightly negative (gross margin ~-2.4%). Losses remain very large versus sales (net margin ~-222%), with negative EBIT and EBITDA margins as well. While the prior annual period (2025) had positive gross margin (~13.3%), the business is still structurally unprofitable with persistent net losses across the history provided.
Balance Sheet
9
Very Negative
The balance sheet is highly stressed with negative shareholders’ equity in TTM (about -$3.8M) and elevated debt (~$5.8M) relative to a small asset base (~$3.7M). Negative equity makes leverage risk materially higher and limits financial flexibility. Debt has also increased versus the most recent annual period (2025), reinforcing refinancing and liquidity sensitivity if operating performance does not improve.
Cash Flow
14
Very Negative
Cash generation is weak: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are both meaningfully negative (about -$2.75M and -$2.77M, respectively), implying continued cash burn. A positive free cash flow growth figure is a modest improvement signal, but it is from a negative base and does not change that the company is funding ongoing losses and operations with external capital or balance-sheet resources.
Breakdown
TTM
Jul 2025
Jul 2024
Jul 2023
Jul 2021
Jul 2020
Income Statement
Total Revenue
1.83M
3.71M
1.62M
3.05M
4.15M
1.69M
Gross Profit
-43.88K
494.39K
-412.85K
-270.42K
2.12M
373.27K
EBITDA
-2.48M
-1.91M
-3.34M
-5.45M
252.17K
-1.51M
Net Income
-4.06M
-3.37M
-4.27M
-6.05M
-543.00K
-1.81M
Balance Sheet
Total Assets
3.68M
2.76M
3.96M
4.16M
6.58M
1.86M
Cash, Cash Equivalents and Short-Term Investments
926.84K
354.03K
56.27K
324.05K
5.02M
251.58K
Total Debt
5.81M
5.58M
2.94M
2.28M
1.38M
1.06M
Total Liabilities
7.50M
7.49M
6.78M
4.77M
3.71M
2.75M
Stockholders Equity
-3.83M
-4.73M
-2.81M
-612.07K
2.88M
-889.52K
Cash Flow
Free Cash Flow
-2.77M
-1.64M
-2.26M
-3.49M
401.48K
-1.38M
Operating Cash Flow
-2.75M
-1.60M
-2.23M
-2.46M
432.92K
-1.33M
Investing Cash Flow
-20.13K
-37.52K
-31.32K
-1.03M
-31.44K
-47.92K
Financing Cash Flow
3.46M
1.93M
1.99M
1.18M
4.36M
1.45M
Cymat Technologies Technical Analysis
Technical Analysis Sentiment
Negative
Last Price0.12
Price Trends
50DMA
0.10
Negative
100DMA
0.11
Negative
200DMA
0.13
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
33.12
Neutral
STOCH
-11.11
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CYM, the sentiment is Negative. The current price of 0.12 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.10, and below the 200-day MA of 0.13, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 33.12 is Neutral, neither overbought nor oversold. The STOCH value of -11.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:CYM.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 12, 2026